Jacques Galipeau, MD
Position title: Associate Dean for Therapeutics Development and Don and Marilyn Anderson Professor of Oncology
Email: jgalipeau@wisc.edu
Phone: (608) 262-6701
Address:
WI Institute Medical Research
1111 Highland Ave
Madison, WI 53705-2275
- Organ System/Disease Focus:
- Crohn's disease, GVHD, Multiple Sclerosis and neurodegenerative disease, cancer immunotherapy, tissue injury
- Aligned Research Focus:
- Mesenchymal stromal cells basic science and translational use, cell culture, B-regulatory cells, NK cells, activated lymphoid cells
News Releases:
Research Description:
Jacques Galipeau, MD is the Don and Marilyn Anderson Professor and Associate Dean for Therapeutics Development at the UW School of Medicine and Public Health. Dr. Galipeau is an academic health center biopharmaceutical leader with broad experience leading groups responsible for discovery research, GMP compliant cell manufacture, clinical trial design, FDA regulatory approval of clinical trials within academia and execution spanning pre-clinical to first-in-human studies across multiple therapeutic areas. He is the founding director of the University of Wisconsin Program for Advanced Cell Therapy. The mission of this program is to develop personalized cell therapies for immune and malignant disorders and to promote and deploy first-in-human clinical trials of UW-Madison cell therapy innovations to improve outcomes for children and adults. He is a practicing hematologist and internationally recognized expert in discovery science and translational development of mesenchymal stromal cell therapies. Innovator in the field of engineered synthetic cytokines as novel pharmaceutical means of treating immune disorders such as colitis, multiple sclerosis, diabetes and cancer. Dr Galipeau is immediate past President (2022-2024) of the International Society of Cell Therapy.
Website: www.pact.wisc.edu